All companies
Nanosonics logo

What smart money is saying about NanosonicsAustralia flag

NAN.AX · Healthcare · Medical - Instruments & Supplies · Market cap $829M

1 fund in our archive has pitched Nanosonics — most recently Forager in March 2025.

Company profile

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Get an email when a fund writes about it

Fund coverage · 1 thesis

  • Forager
    March 2025

    With dominant market share, razor-blade economics, and a high-margin growth engine in Trophon, Nanosonics offers strong fundamentals—while Coris adds a powerful long-term kicker.

    Read the full thesis

Read every full thesis on Nanosonics

Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans